Pharmacology of Drugs for Sexually Transmitted Infections: Chancroid, Trichomonas, and Chlamydia
Pharmacology of Drugs for Sexually Transmitted Infections: Chancroid, Trichomonas, and Chlamydia is organized by Nurse.com - OnCourse Learning Corporation.
Course Originally Released on: 04/12/2023
Date of Most Recent Review: 4/12/2023
Course Termination/ Update Date: 12/31/2026
Description:
The most recent sexually transmitted infection (STI) report from the Centers for Disease Control and Prevention (CDC) shows that about 1 in 5 people in the U.S. had an STI on any given day, and STIs acquired in 2018 alone will cost the healthcare system nearly $16 billion in direct healthcare costs (CDC, 2022a).
Some racial and ethnic groups have higher rates of STI infection. This is due to healthcare inequity and social conditions and not genetic heritage. Social conditions more likely to affect minority groups include poverty and lower education levels. Accessing and/or trusting the healthcare system may be difficult for some groups. In areas with higher rates of STIs, sexually active people have greater odds of becoming infected (CDC, 2020). Women of all races and ethnicities are also disproportionally affected by STIs and often have more severe health and reproductive consequences from infection than men (CDC, n.d.).
Goal and Learning Outcomes:
The goal of this course is to provide an overview of pharmacological options for those members of the healthcare team who may treat chancroid, trichomoniasis, and chlamydia infections.
All drug-related information cited in this course was obtained from the manufacturer package inserts accessed February 19, 2023, unless otherwise noted.
After taking this course, you should be able to:
• Recognize the signs and symptoms, diagnostic criteria, and treatments for chancroid.
• Identify the signs and symptoms, diagnostic criteria, and treatments for trichomoniasis.
• Recall the signs and symptoms, diagnostic criteria, and treatments for chlamydia.